Z-2751-2017 Class II Terminated

Recalled by Becton Dickinson & Company — Franklin Lakes, NJ

FDA device recall Z-2751-2017 was initiated by Becton Dickinson & Company on Sep 16, 2016 and is designated Class II. Reason for recall: BD identified that several lots did not receive the specified dose of irradiation necessary to meet the Sterility Assurance Level (SAL) required of 10-6. The recall status is terminated (terminated Mar 20, 2018). Affected quantity: 648,000 units.

Recall details

Product Type
Devices
Report Date
Jul 26, 2017
Initiation Date
Sep 16, 2016
Termination Date
Mar 20, 2018
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
648,000 units

Product description

BD 3ml Syringe Luer-Lok" Tip Catalog 309657 The BD Single Use, Hypodermic Syringe is intended for use by health care professionals for general purpose fluid aspiration/injection

Reason for recall

BD identified that several lots did not receive the specified dose of irradiation necessary to meet the Sterility Assurance Level (SAL) required of 10-6.

Distribution pattern

Nationwide Distribution

Code information

6061746 2021-02 6082982 2021-02 6089821 2021-03 6117858 2021-04 6117863 2021-04 6117889 2021-04 6117891 2021-04 6146962 2021-04 6173697 2021-05 6173767 2021-06 6173779 2021-06 6208614 2021-07

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-2751-2017
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-2751-2017. Report a data issue: hello@regdatalab.com.